Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boers

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 30, 2023
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanomaLaurens S Ter Maat, Isabella A J van Duin, Sjoerd G Elias, et al.
Cancers|June 10, 2023
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint InhibitorsOlivier J van Not, Thijs T Wind, Rawa K Ismail, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2022
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort studyOlivier J van Not, Melissa M de Meza, Alfons J M van den Eertwegh, et al.
International Journal of Cancer|January 31, 2024
A prediction model for response to immune checkpoint inhibition in advanced melanomaIsabella A J van Duin, Rik J Verheijden, Paul J van Diest, et al.
Scientific Reports|December 31, 2024
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanomaLaurens S Ter Maat, Rob A J De Mooij, Isabella A J Van Duin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2024
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanomaRik J Verheijden, Femke H Burgers, Josephine C Janssen, et al.
International Journal of Cancer|February 27, 2023
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanomaIsabella A J van Duin, Sjoerd G Elias, Alfonsus J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2021
Adjuvant treatment for melanoma in clinical practice - Trial versus realityMelissa M de Meza, Rawa K Ismail, Daan Rauwerdink, et al.
Nature Communications|February 23, 2024
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trialKalijn F Bol, Gerty Schreibelt, Martine Bloemendal, et al.
The New England Journal of Medicine|December 8, 2022
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced MelanomaMaartje W Rohaan, Troels H Borch, Joost H van den Berg, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|March 30, 2023
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanomaLaurens S Ter Maat, Isabella A J van Duin, Sjoerd G Elias, et al.
Cancers|June 10, 2023
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint InhibitorsOlivier J van Not, Thijs T Wind, Rawa K Ismail, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2022
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort studyOlivier J van Not, Melissa M de Meza, Alfons J M van den Eertwegh, et al.
International Journal of Cancer|January 31, 2024
A prediction model for response to immune checkpoint inhibition in advanced melanomaIsabella A J van Duin, Rik J Verheijden, Paul J van Diest, et al.
Scientific Reports|December 31, 2024
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanomaLaurens S Ter Maat, Rob A J De Mooij, Isabella A J Van Duin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2024
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanomaRik J Verheijden, Femke H Burgers, Josephine C Janssen, et al.
International Journal of Cancer|February 27, 2023
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanomaIsabella A J van Duin, Sjoerd G Elias, Alfonsus J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2021
Adjuvant treatment for melanoma in clinical practice - Trial versus realityMelissa M de Meza, Rawa K Ismail, Daan Rauwerdink, et al.
Nature Communications|February 23, 2024
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trialKalijn F Bol, Gerty Schreibelt, Martine Bloemendal, et al.
The New England Journal of Medicine|December 8, 2022
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced MelanomaMaartje W Rohaan, Troels H Borch, Joost H van den Berg, et al.
Pageof 13